Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-17, Stock:NVS, The news for the past five days is as follows:
2019-04-10: NEWS1: What Alcon’s Spinoff Can Teach Bausch Health.NEWS2: 5 Companies Paying High Dividend Yields.NEWS3: Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval.NEWS4: Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval.NEWS5: Alcon Can See Clearly Now.NEWS6: Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval.NEWS7: Analysts Predict 13% Upside For The Holdings of ADRD.NEWS8: Analysts Predict 13% Upside For The Holdings of ADRD.NEWS9: Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug.NEWS10: Q1 Cannabis Wholesale Report: Best-Selling Brands And Products, Pharma, CBD And Interstate Commerce.
2019-04-11: NEWS1: Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon.NEWS2: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS3: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS4: Top Research Reports for McDonald's, Enterprise Products & Charles Schwab.NEWS5: Top Research Reports for McDonald's, Enterprise Products & Charles Schwab.NEWS6: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS7: Top Research Reports for McDonald's, Enterprise Products & Charles Schwab.NEWS8: Intercept Reports Additional Positive Data From NASH Study.NEWS9: Intercept Reports Additional Positive Data From NASH Study.NEWS10: Intercept Reports Additional Positive Data From NASH Study.NEWS11: Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Here’s the Real Problem with Altria Overpaying for CRON Stock.
2019-04-12: NEWS1: Ophthotech Gets Rights to Gene Therapy for BEST Disease.NEWS2: Ophthotech Gets Rights to Gene Therapy for BEST Disease.NEWS3: Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal.NEWS4: Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal.NEWS5: Ophthotech Gets Rights to Gene Therapy for BEST Disease.NEWS6: Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon.NEWS7: Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon.
2019-04-15: NEWS1: Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran.NEWS2: Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran.NEWS3: Alcon Stock Is Back. The Eye-care Company Deserves a Long, Hard Look..
2019-04-16: NEWS1: Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran.NEWS2: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.NEWS3: Allergan Falls as Supreme Court Dismisses Restasis Litigation.NEWS4: Allergan Falls as Supreme Court Dismisses Restasis Litigation.NEWS5: Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA.NEWS6: Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA.NEWS7: Marijuana ETF Down 9% in Past Month: Time to Enter the Space?.NEWS8: Allergan Falls as Supreme Court Dismisses Restasis Litigation.NEWS9: Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA.NEWS10: The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives.

Answer: Decrease